Arsenic Trioxide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Arsenic Trioxide Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Sep 21, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-637-10
- Dosage Form
- Injection
- Presentation
- Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10)
- Initial Posting
- Sep 21, 2026